BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang DH, Pracros JP. Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study. Acta Radiol 2019;60:1450-6. [PMID: 31027425 DOI: 10.1177/0284185119840649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Moon WJ, Cho YA, Hahn S, Son HM, Woo SK, Lee YH. The Pattern of Use, Effectiveness, and Safety of Gadoteric Acid (Clariscan) in Patients Undergoing Contrast-Enhanced Magnetic Resonance Imaging: A Prospective, Multicenter, Observational Study. Contrast Media Mol Imaging 2021;2021:4764348. [PMID: 34803545 DOI: 10.1155/2021/4764348] [Reference Citation Analysis]
2 Farmakis SG, Hardy AK, Mahmoud SY, Wilson-Flewelling SA, Tao TY. Safety of gadoterate meglumine in children younger than 2 years of age. Pediatr Radiol 2020;50:855-62. [PMID: 32055917 DOI: 10.1007/s00247-020-04626-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nielsen YW, Thomsen HS. Trends in contrast media research the last 100 years. Acta Radiol 2021;:2841851211051014. [PMID: 34636678 DOI: 10.1177/02841851211051014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]